Supplemental material
Open access
7,846
Views
4
CrossRef citations to date
0
Altmetric
Report
Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity
Catherine Y Liua Adimab, LLC, NH, USAView further author information
, Cory L Ahonena Adimab, LLC, NH, USAView further author information
, Michael E Browna Adimab, LLC, NH, USAView further author information
, Ling Zhoua Adimab, LLC, NH, USAView further author information
, Martin Welinb SARomics Biostructures AB, Lund, SwedenView further author information
, Eric M Kraulanda Adimab, LLC, NH, USAView further author information
, Robert Pejchala Adimab, LLC, NH, USAView further author information
, Paul F Widbooma Adimab, LLC, NH, USAView further author information
& Michael B Battlesa Adimab, LLC, NH, USACorrespondence[email protected]
https://orcid.org/0000-0002-5321-7460View further author information
Article: 2189974
|
Received 28 Nov 2022, Accepted 06 Mar 2023, Published online: 29 Mar 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.